Thiophene-Pyrazolourea Derivatives as Potent, Orally Bioavailable, and Isoform-Selective JNK3 Inhibitors.
Thiophene-Pyrazolourea Derivatives as Potent, Orally Bioavailable, and Isoform-Selective JNK3 Inhibitors.
复制标题
噻吩-吡唑啉衍生物作为有效的、口服生物可利用的和异构体选择性JNK 3抑制剂。
DOI:
10.1021/acsmedchemlett.0c00533
复制
发表时间:
2021-01-14
影响因子:
4.2
通讯作者:
Yoon SO
中科院分区:
文献类型:
--
作者:
Feng Y;Park H;Bauer L;Ryu JC;Yoon SO
Potent JNK3 isoform selective inhibitors were developed from a thiophenyl-pyrazolourea scaffold. Through structure activity relationship (SAR) studies utilizing enzymatic and cell-based assays, and in vitro and in vivo drug metabolism and pharmacokinetic (DMPK) studies, potent and highly selective JNK3 inhibitors with oral bioavailability and brain penetrant capability were developed. Inhibitor 17 was a potent and isoform selective JNK3 inhibitor (IC50 = 35 nM), had significant inhibition to only JNK3 in a panel profiling of 374 wild-type kinases, had high potency in functional cell-based assays, had high stability in human liver microsome (t1/2 = 66 min) and a clean CYP-450 inhibition profile, and was orally bioavailable and brain penetrant. Moreover, cocrystal structures of compounds 17 and 27 in human JNK3 were solved at 1.84 Å, which showed that these JNK3 isoform selective inhibitors bound to the ATP pocket, had interactions in both hydrophobic pocket-I and hydrophobic pocket-II.
登录
查看更多内容
影响因子:
2.7
作者:
Jung, Hoyong;Aman, Waciar;Hah, Jung-Mi
通讯作者:
Hah, Jung-Mi
影响因子:
4.6
作者:
Park H;Iqbal S;Hernandez P;Mora R;Zheng K;Feng Y;LoGrasso P
通讯作者:
LoGrasso P
影响因子:
--
作者:
Zhang T;Inesta-Vaquera F;Niepel M;Zhang J;Ficarro SB;Machleidt T;Xie T;Marto JA;Kim N;Sim T;Laughlin JD;Park H;LoGrasso PV;Patricelli M;Nomanbhoy TK;Sorger PK;Alessi DR;Gray NS
通讯作者:
Gray NS
DOI:
10.1073/pnas.2336254100
发表时间:
2003-12-09
影响因子:
11.1
作者:
Kuan, CY;Whitmarsh, AJ;Rakic, P
通讯作者:
Rakic, P
DOI:
10.1080/14756366.2019.1705294
发表时间:
2020-01-01
影响因子:
5.6
作者:
Oh, Youri;Jang, Miyoung;Hah, Jung-Mi
通讯作者:
Hah, Jung-Mi